tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Abivax $400M Spot Secondary; price range $62.50-$65.00

Leerink, Piper Sandler, Guggenheim and LifeSci Capital are acting as joint book running managers for the offering.

Meet Your ETF AI Analyst

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1